Linda Coleman is the Chief Officer for Research Ethics and Quality at CTAC. Ms. Coleman pairs deep policy, regulatory, and operational leadership with breadth spanning research integrity, human research protection, bioethics, and access to research and health care—the foundation she brings to this role.
She is currently the Associate Vice Provost for Research Policy & Integrity at Stanford University, where she oversees areas including research security, conflict of interest, and the responsible and ethical conduct of research. Before joining Stanford, she was the Director of the Human Research Protection Program at Yale University. Prior to Yale, Ms. Coleman held progressive roles, including Vice President of Legal & Regulatory Affairs and Director of Regulatory Affairs & General Counsel, at Quorum Review (now part of Advarra), an independent IRB and consulting organization serving institutional, independent, and international research sites. Earlier in her career, she worked as an Attorney at Bennett, Bigelow & Leedom, focusing on health law, Medicare and Medicaid reimbursement, litigation, behavioral health, and employment law.
Ms. Coleman is actively engaged in the research community and has contributed her expertise to various advisory and governance roles. She was a member of the Secretary’s Advisory Committee on Human Research Protections (SACHRP) from 2019 to 2022, served as Co-Chair of the SACHRP Subcommittee (SAS) from 2023 to 2024, and chaired the SACHRP Subcommittee from mid-2024 until it was disbanded in 2025. She serves on committees and boards, including the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Public Responsibility in Medicine & Research (PRIM&R), the Collegial, Peer-Reviewed IRB Quality Assurance group (Care-Q), the National Advisory Committee on Human Research Protections (NACHRP), the Collaborative Institutional Training Initiative (CITI Program), and Partners for Patients NGO. She is a frequent speaker on good clinical practice, decentralized clinical trials, data privacy and protection, research quality and compliance, the responsible and ethical conduct of research, research capacity building, bioethics, and improving access to health care and research participation.
